Hydroxy-6-heteroarylphenanthridines and their use as PDE4...

Details Hydroxy-6-heteroarylphenanthridines and their use as PDE4... Hydroxy-6-heteroarylphenanthridines and their use as PDE4...

2011-08-23

2011-08-23

Sznaidman, Marcos (Department: 1628)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

08003798

ABSTRACT:
Compounds of the formula Iin which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.

REFERENCES:
patent: 6008215 (1999-12-01), Flockerzi
patent: 6121279 (2000-09-01), Gutterer
patent: 6127378 (2000-10-01), Gutterer
patent: 6191138 (2001-02-01), Gutterer
patent: 6214839 (2001-04-01), Gutterer
patent: 6306869 (2001-10-01), Flockerzi
patent: 6410551 (2002-06-01), Gutterer
patent: 6476025 (2002-11-01), Gutterer
patent: 6479505 (2002-11-01), Gutterer
patent: 6534518 (2003-03-01), Gutterer
patent: 6534519 (2003-03-01), Gutterer
patent: 6538005 (2003-03-01), Gutterer
patent: 6884802 (2005-04-01), Schmidt
patent: 6936622 (2005-08-01), Flockerzi
patent: 7329676 (2008-02-01), Kautz et al.
patent: 7423046 (2008-09-01), Kautz
patent: 7585872 (2009-09-01), Kautz et al.
patent: 7632844 (2009-12-01), Kautz et al.
patent: 2004/0038979 (2004-02-01), Schmidt
patent: 2004/0097537 (2004-05-01), Flockerzi
patent: 2005/0239817 (2005-10-01), Kautz et al.
patent: 2005/0239818 (2005-10-01), Kautz et al.
patent: 2006/0116518 (2006-06-01), Flockerzi et al.
patent: 2007/0167482 (2007-07-01), Kautz
patent: 2007/0185149 (2007-08-01), Kautz et al.
patent: 2007/0191413 (2007-08-01), Kautz et al.
patent: 2007/0191414 (2007-08-01), Kautz et al.
patent: 2007/0259909 (2007-11-01), Kautz et al.
patent: 2008/0319067 (2008-12-01), Kautz et al.
patent: 2009/0170892 (2009-07-01), Kautz et al.
patent: 0 490 823 (1992-06-01), None
patent: 1270577 (2006-12-01), None
patent: 97/28131 (1997-08-01), None
patent: 97/35854 (1997-10-01), None
patent: 98/21208 (1998-05-01), None
patent: 98/40382 (1998-09-01), None
patent: 98/55481 (1998-12-01), None
patent: 99/05111 (1999-02-01), None
patent: 99/05112 (1999-02-01), None
patent: 99/05113 (1999-02-01), None
patent: 99/57118 (1999-11-01), None
patent: 00/12501 (2000-03-01), None
patent: 00/42017 (2000-07-01), None
patent: 00/42018 (2000-07-01), None
patent: 00/42019 (2000-07-01), None
patent: 00/42020 (2000-07-01), None
patent: 00/42034 (2000-07-01), None
patent: 01/51470 (2001-07-01), None
patent: 02/05616 (2002-01-01), None
patent: 02/06238 (2002-01-01), None
patent: 02/06270 (2002-01-01), None
patent: 02/066476 (2002-08-01), None
patent: 2004/018431 (2004-03-01), None
patent: 2004/018465 (2004-03-01), None
patent: 2004/019944 (2004-03-01), None
patent: 2004/019945 (2004-03-01), None
patent: 2005/077906 (2005-08-01), None
patent: 2005/084104 (2005-09-01), None
patent: 2005/085203 (2005-09-01), None
patent: 2005/085225 (2005-09-01), None
patent: 2005/087744 (2005-09-01), None
patent: 2005/087745 (2005-09-01), None
patent: 2005/090311 (2005-09-01), None
patent: 2006/092422 (2006-09-01), None
Patel et. al. (Expert Opinion on Investigational Drugs (2003) 12:623-633).
Dorwald F. A. (Side reactions in organic synthesis, 2005, Wiley, VCH, Weinheim, p. IX of Preface).
Baumer et al., “Highly Selective Phosphodiesterase 4 Inhibitors for the Treatment of Allergic Skin Diseases and Psoriasis”, Infl. and Allergy—Drug Targets, 2006, 6, 17-26.
Kamentani et al., “Cyclised Products in the Synthesis of 6-Substituted Phananthridines by Phenolic Cyclisation”, J. Chem. Soc., pp. 1805-1808, 1971.
Govindachari et al., “Application of the Bruckner Method to the Synthesis of Phenanthridine Derivatives”, J. Chem. Soc., pp. 4280-4283, 1956.
Sugasawa et al., “Syhthese Partiell Hydrierter Phenanthridin-Derivate (I)”, Chem. Ber., pp. 675-678, 1939.
Cecil textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition, vol. 1, 1004-1010, 1996.
Krogel et al., Expert Opin. Investig. Drugs, 16(1), 109-124, 2007.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
West, Anthony R., “Solid State Chemistry and its Applications”, Wiley, New York, 1988, pp. 358 & 365.
Souness, J.E., “Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors”,Immunopharmacology, vol. 47, pp. 127-162, (2000).
Dyke, H.J., et al., “Update on the therapeutic potential of PDE4 inhibitors”,Expert Opin. Investig. Drugs, vol. 11, No. 1, pp. 1-13, (2002).
Montana, J.G., et al., “Chapter 5. Phosphodiesterase 4 Inhibitors”,Annual Reports in Medicinal Chemistry, vol. 36, pp. 41-56, (2001).
Schmidt, B.M.W., et al., “The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis”,J Allergy Clin Immunol, vol. 108, pp. 530-536, 2001).

Affiliated with

Also associated with

Rating

Hydroxy-6-heteroarylphenanthridines and their use as PDE4... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxy-6-heteroarylphenanthridines and their use as PDE4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxy-6-heteroarylphenanthridines and their use as PDE4... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2657602